- Home
- Publications
- Publication Search
- Publication Details
Title
Immunology and immunotherapy of cholangiocarcinoma
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-25
DOI
10.1038/s41575-022-00741-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
- (2022) Sophie Cousin et al. EUROPEAN JOURNAL OF CANCER
- Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
- (2022) Laura Izquierdo-Sanchez et al. JOURNAL OF HEPATOLOGY
- Identification of neoantigens for individualized therapeutic cancer vaccines
- (2022) Franziska Lang et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
- (2022) Cecilia Monge et al. ONCOLOGIST
- Tertiary lymphoid structures in cancer
- (2022) Ton N. Schumacher et al. SCIENCE
- MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma
- (2022) Barbara Oliviero et al. OncoImmunology
- Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
- (2022) Rosemina Merchant et al. Journal for ImmunoTherapy of Cancer
- How I treat biliary tract cancer
- (2022) A. Lamarca et al. ESMO Open
- Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
- (2022) Daisuke Konishi et al. BRITISH JOURNAL OF CANCER
- CXCR2 inhibition enables NASH-HCC immunotherapy
- (2022) Jack Leslie et al. GUT
- Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
- (2022) Miguel A Martin-Serrano et al. GUT
- Biology of IDH mutant cholangiocarcinoma
- (2022) Meng‐Ju Wu et al. HEPATOLOGY
- Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
- (2022) Tao Xia et al. Journal of Hematology & Oncology
- EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
- (2022) Qibiao Wu et al. Cancer Discovery
- Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
- (2022) Methi Wathikthinnakon et al. Scientific Reports
- Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
- (2022) Do-Youn Oh et al. Lancet Gastroenterology & Hepatology
- Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma.
- (2022) Vinod P. Balachandran et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut-liver axis: Pathophysiological concepts and clinical implications
- (2022) Herbert Tilg et al. Cell Metabolism
- Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
- (2022) Aveline Filliol et al. NATURE
- Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis
- (2022) Bridget P. Keenan et al. Cell Reports
- Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
- (2021) Nathan D. Mathewson et al. CELL
- MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
- (2021) Chi Ma et al. CELLULAR IMMUNOLOGY
- Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
- (2021) Xing Huang et al. Molecular Cancer
- Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma
- (2021) Massa Saab et al. PLoS One
- Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3
- (2021) Zhengjun Zhou et al. Journal for ImmunoTherapy of Cancer
- Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
- (2021) Silvia Affo et al. CANCER CELL
- Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
- (2021) Yao He et al. Cell Metabolism
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- The microbiome and human cancer
- (2021) Gregory D. Sepich-Poore et al. SCIENCE
- Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
- (2021) Kamonlapat Supimon et al. Scientific Reports
- PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology
- (2021) Zheng Chen et al. Frontiers in Immunology
- 959O Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
- (2021) D.S. Hong et al. ANNALS OF ONCOLOGY
- Microbiome and cancer
- (2021) Nyssa Cullin et al. CANCER CELL
- Examining the gut-liver axis in liver cancer using organoid models
- (2021) Dmitrii Shek et al. CANCER LETTERS
- Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma
- (2021) Shu Ling Chen et al. CLINICAL CANCER RESEARCH
- Current strategies for intratumoural immunotherapy – Beyond immune checkpoint inhibition
- (2021) Jianda Yuan et al. EUROPEAN JOURNAL OF CANCER
- The Immunogenomic Landscape of Resected Intrahepatic Cholangiocarcinoma
- (2021) Fernando Carapeto et al. HEPATOLOGY
- CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma via 5‐lipoxygenase
- (2021) Yuli Lin et al. HEPATOLOGY
- Comparison of Clinical Features and Outcomes between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States
- (2021) Yi‐Te Lee et al. HEPATOLOGY
- Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
- (2021) Mélanie Desbois et al. IMMUNOLOGICAL REVIEWS
- Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
- (2021) Juliette Paillet et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- (2021) Lichun Ma et al. JOURNAL OF HEPATOLOGY
- The implications of IDH mutations for cancer development and therapy
- (2021) Christopher J. Pirozzi et al. Nature Reviews Clinical Oncology
- Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns
- (2021) Mason A. Israel et al. ONCOLOGIST
- IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
- (2021) Xiao Xiang et al. Advanced Science
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
- (2021) Andrew X. Zhu et al. JAMA Oncology
- Distinct immune signatures in peripheral blood predict chemosensitivity in intrahepatic cholangiocarcinoma patients
- (2021) Tong Wu et al. Engineering
- First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
- (2021) Debbie Robbrecht et al. BRITISH JOURNAL OF CANCER
- Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
- (2021) Liangqing Dong et al. CANCER CELL
- Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
- (2021) Zhiwei Wang et al. Cancer Cell International
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma
- (2021) Christine L. Zimmer et al. HEPATOLOGY
- Pan-cancer single-cell landscape of tumor-infiltrating T cells
- (2021) Liangtao Zheng et al. SCIENCE
- Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma
- (2021) Meng-Ju Wu et al. Cancer Discovery
- G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
- (2021) Mahmoud S. Alghamri et al. Science Advances
- Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
- (2021) Jinzhu Mao et al. Journal for ImmunoTherapy of Cancer
- Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
- (2021) Xiaofeng Chen et al. Journal for ImmunoTherapy of Cancer
- A Retrospective Study of Lenvatinib Monotherapy or Combined With Programmed Cell Death Protein 1 Antibody in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma in China
- (2021) Sihui Zhu et al. Frontiers in Oncology
- Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
- (2021) Guang-Yu Ding et al. JOURNAL OF HEPATOLOGY
- Systemic therapies for intrahepatic cholangiocarcinoma
- (2020) Robin Kate Kelley et al. JOURNAL OF HEPATOLOGY
- Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
- (2020) Andriy Marusyk et al. CANCER CELL
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies
- (2020) Sarina A. Piha-Paul et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
- (2020) Robert Montal et al. JOURNAL OF HEPATOLOGY
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
- (2020) Richard D. Kim et al. JAMA Oncology
- Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
- (2020) Changhoon Yoo et al. Journal for ImmunoTherapy of Cancer
- Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
- (2020) Robert J. Motzer et al. CANCER
- Intratumoral γδ T‐cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma
- (2020) Na Zhao et al. HEPATOLOGY
- Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
- (2020) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
- (2020) Min Zhang et al. JOURNAL OF HEPATOLOGY
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers
- (2020) Oliver Klein et al. JAMA Oncology
- Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
- (2020) Yongyan Chen et al. Cellular & Molecular Immunology
- Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
- (2020) Emilien Loeuillard et al. JOURNAL OF CLINICAL INVESTIGATION
- LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1
- (2020) Zhuo Liu et al. LIFE SCIENCES
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- Concepts of extracellular matrix remodelling in tumour progression and metastasis
- (2020) Juliane Winkler et al. Nature Communications
- Evolution of the Experimental Models of Cholangiocarcinoma
- (2020) Annamaria Massa et al. Cancers
- Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
- (2020) James C. Lee et al. Science Immunology
- Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
- (2020) Chang Gon Kim et al. EUROPEAN JOURNAL OF CANCER
- Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells
- (2020) Thanich Sangsuwannukul et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- CD40-mediated immune cell activation enhances response to anti-PD1 in murine intrahepatic cholangiocarcinoma
- (2020) Laurence P. Diggs et al. JOURNAL OF HEPATOLOGY
- PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome
- (2020) Lingyu Tian et al. World Journal of Surgical Oncology
- Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma
- (2020) Qianfei Zhang et al. Cancer Discovery
- Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice
- (2020) Padma Kadiyala et al. JOURNAL OF CLINICAL INVESTIGATION
- Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis
- (2020) Sophia Heinrich et al. JOURNAL OF HEPATOLOGY
- Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
- (2020) Yu-Hua Huang et al. JOURNAL OF HEPATOLOGY
- Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC).
- (2019) Tatsuya Ioka et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
- (2019) Anastasia G. Tavianatou et al. FEBS Journal
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors
- (2019) Bin Fan et al. INVESTIGATIONAL NEW DRUGS
- Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
- (2019) Deepali V. Sawant et al. NATURE IMMUNOLOGY
- Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response
- (2019) Rajarsi Mandal et al. SCIENCE
- The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
- (2019) Malek Kreidieh et al. Journal of Oncology
- Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma
- (2019) Xiaodong Jia et al. HEPATOLOGY
- Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response
- (2019) Patrick A. Baeuerle et al. Nature Communications
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review
- (2019) Junmin Song et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: a systematic review and meta-analysis
- (2019) Oliver Clements et al. JOURNAL OF HEPATOLOGY
- Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study
- (2019) Makoto Ueno et al. Lancet Gastroenterology & Hepatology
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies
- (2019) Jennifer Y Ju et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma
- (2019) Sylvie Job et al. HEPATOLOGY
- Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
- (2019) Yuli Lin et al. NEOPLASIA
- Animal models of cholangiocarcinoma
- (2018) Emilien Loeuillard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival
- (2018) Paula Fluxá et al. BMC CANCER
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
- (2018) Daniel Rojas-Sepúlveda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- NKG2D–MICA Interaction: A Paradigm Shift in Innate Recognition
- (2018) Mathieu Bléry et al. JOURNAL OF IMMUNOLOGY
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)
- (2018) Hendrik‐Tobias Arkenau et al. ONCOLOGIST
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
- (2018) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
- (2018) Luc Cabel et al. Nature Reviews Clinical Oncology
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
- (2018) Benjamin Goeppert et al. BRITISH JOURNAL OF CANCER
- Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer
- (2018) Changqing Xie et al. HEPATOLOGY
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Mutant IDH1 regulates the tumor-associated immune system in gliomas
- (2017) Nduka M. Amankulor et al. GENES & DEVELOPMENT
- Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
- (2017) Gary Kohanbash et al. JOURNAL OF CLINICAL INVESTIGATION
- Global trends and predictions in hepatocellular carcinoma mortality
- (2017) Paola Bertuccio et al. JOURNAL OF HEPATOLOGY
- CD8+T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
- (2017) Stalin Chellappa et al. JOURNAL OF IMMUNOLOGY
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- New Horizons for Precision Medicine in Biliary Tract Cancers
- (2017) Juan W. Valle et al. Cancer Discovery
- PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
- (2017) Jacqueline Fontugne et al. Oncotarget
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma
- (2016) Faiz Gani et al. ANNALS OF SURGICAL ONCOLOGY
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
- (2016) João Sabino et al. GUT
- IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
- (2016) Rushikesh Sudam Patil et al. INTERNATIONAL JOURNAL OF CANCER
- Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
- (2016) Markus W. Löffler et al. JOURNAL OF HEPATOLOGY
- PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma
- (2015) F. Sabbatino et al. CLINICAL CANCER RESEARCH
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
- (2015) Shlomi Finkin et al. NATURE IMMUNOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of neutrophil distribution in cholangiocarcinoma
- (2015) Zhi-Yuan Mao WORLD JOURNAL OF GASTROENTEROLOGY
- Roles of liver fluke infection as risk factor for cholangiocarcinoma
- (2014) Paiboon Sithithaworn et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
- (2013) A. Aruga et al. CLINICAL CANCER RESEARCH
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
- (2012) J. C. Mertens et al. CANCER RESEARCH
- Role of the stromal-derived factor-1 (SDF-1)–CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma
- (2012) Alessandra Gentilini et al. JOURNAL OF HEPATOLOGY
- Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma
- (2012) Liping Yu et al. Journal of Cancer
- Transmembrane Collagen Receptors
- (2011) Birgit Leitinger Annual Review of Cell and Developmental Biology
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
- (2011) Tania M. Welzel et al. HEPATOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
- (2010) Kusumawadee Utispan et al. Molecular Cancer
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells
- (2010) J. J. O'Shea et al. SCIENCE
- The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses
- (2009) Valérie Gaboriau-Routhiau et al. IMMUNITY
- The antecedents of biliary cancer: a primary care case–control study in the United Kingdom
- (2008) M J Grainge et al. BRITISH JOURNAL OF CANCER
- The inhibitory collagen receptor LAIR-1 (CD305)
- (2007) L. Meyaard JOURNAL OF LEUKOCYTE BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started